# Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal Healthy Volunteers by the Subcutaneous Route

> **NCT06126042** · PHASE1 · UNKNOWN · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 330 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Test Product
- **DRUG:** Reference product
- **DRUG:** Reference Medicinal Product

## Key facts

- **NCT ID:** NCT06126042
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-03
- **Primary completion:** 2024-04
- **Final completion:** 2024-07
- **Target enrollment:** 330 (ESTIMATED)
- **Last updated:** 2023-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06126042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06126042, "Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal Healthy Volunteers by the Subcutaneous Route". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06126042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*